In this study, we presented evidence that miR-30d functions as a tumor-suppressive molecule, directly or indirectly targeting key glycolytic genes independent of oncogenic transcription factors HIF1a and MYC, and rewiring the cellular metabolism to reduce glycolysis and repress PDAC tumorigenesis. This evidence concerns the gene MYC and neoplasm.